U.S. stock-index futures climbed, indicating that equity benchmarks will extend a rally that has already produced the biggest two-day gains since April.
Intercept Pharmaceuticals Inc. soared 58 percent in early New York trading after a clinical trial met its primary goal.
Futures on the Standard & Poor’s 500 Index expiring in September gained 0.3 percent to 1,937.8 at 6:08 a.m. in New York. Dow Jones Industrial Average contracts climbed 40 points, or 0.2 percent, to 16,555 today.
The S&P 500 rose 1.4 percent in the past two trading days as reports indicated that Russia wanted to de-escalate the conflict in eastern Ukraine and the Kremlin had ended military exercises near the border with its neighbor.
Russia’s Emergencies Ministry said a proposed aid convoy will take days to reach Ukraine, Itar-Tass reported today. The U.S., the European Union and NATO warned President Vladimir Putin yesterday against using the mission as a pretext for military intervention in support of the separatists.
Source : Bloomberg